Next-Generation Imaging

Latest News

PSMA PET/CT can reveal prostate cancer recurrences before biochemical criteria met
PSMA PET/CT can reveal prostate cancer recurrences before biochemical criteria met

October 29th 2024

“The majority (76%) of patients not yet meeting the Phoenix criteria did have PSMA-avid lesions on PSMA-PET, suggesting [prostate cancer] recurrence," says Evelien J E van Altena.

Trial launches of 61Cu-based radiotracer in PSMA-positive prostate cancer
Trial launches of 61Cu-based radiotracer in PSMA-positive prostate cancer

October 23rd 2024

68Ga-PSMA and 18F-Fluciclovine demonstrate ability to alter radiation target volumes
68Ga-PSMA and 18F-Fluciclovine demonstrate ability to alter radiation target volumes

October 16th 2024

18F rhPSMA-7.3 PET/MRI demonstrates high detection in recurrent prostate cancer
18F rhPSMA-7.3 PET/MRI demonstrates high detection in recurrent prostate cancer

October 15th 2024

Phase 3 trial of 64Cu-SAR-bisPSMA in BCR of prostate cancer set to launch in 2025
Phase 3 trial of 64Cu-SAR-bisPSMA in BCR of prostate cancer set to launch in 2025

October 14th 2024

Video Series
Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.